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Study Objective. To examine associations between age at initiation of
prescription stimulants and illicit use and abuse of prescription stimulants,
alcohol, and other drugs among college students in the United States.
Design. Web-based survey of college students.
Setting. A large (full-time undergraduate population > 20,000) university.
Intervention. A Web-based survey was sent to a random sample of 5389
undergraduate college students plus an additional 1530 undergraduate
college students of various ethnic backgrounds over a 2-month period.
Measurements and Main Results. Alcohol abuse was assessed by including a
modified version of the Cut Down, Annoyance, Guilt, Eye-opener (CAGE)
instrument.  Drug use–related problems were assessed with a slightly
modified version of the Drug Abuse Screening Test, short form (DAST-10).
The final sample consisted of 4580 undergraduate students (66% response
rate).  For the analyses, five subgroups were created based on age at
initiation of prescription stimulant use:  no prescription stimulant use,
grades kindergarten (K)–4, grades 5–8, grades 9–12, and college.
Undergraduate students to whom stimulants were prescribed in grades K–4
reported similar rates of alcohol and other drug use compared with that of
the group that had no prescription stimulant use.  For example, students
who started prescription stimulants in grades K–4 were no more likely to
report coingestion of alcohol and illicit prescription stimulants (odds ratio
[OR] 1.4, 95% confidence interval [CI] 0.2–11.5, NS] than the group that
had no prescription stimulant use.  However, undergraduate students
whose prescription stimulant use began in college had significantly higher
rates of alcohol and other drug use.  For example, students who started a
prescription stimulant in college were almost 4 times as likely (OR 3.7,
95% CI 1.9–7.1, p<0.001) to report at least three positive indicators of drug
abuse on the DAST-10 compared with the group that had no prescription
stimulant use.
Conclusions. In concordance with results of previous research, these results
indicate that initiation of prescription stimulants during childhood is not
associated with increased future use of alcohol and other drugs.
Key Words:  prescription stimulants, substance abuse, drug abuse, attention-
deficit–hyperactivity disorder, ADHD, young adults, college students.
(Pharmacotherapy 2007;27(5):666–674)
During the past decade, the illicit use of
prescription drugs, including prescription
stimulants, has become the second most common
form of illicit drug use among college students in
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the United States.1 National data from 2003
showed that college students aged 19–22 years
were more likely to report illicit use of Ritalin
(Novartis Pharmaceuticals Corp., East Hanover,
NJ) than the same age population not enrolled in
college.1 To further highlight this problem,
associations have been found between the illicit
use of prescription stimulants and higher rates of
cigarette smoking, heavy episodic drinking,
marijuana use, and cocaine use among
adolescents, young adults,2, 3 and college students
in the United States.4–7 An association has also
been found between the illicit use of prescription
stimulants and the age at which an individual
reports the initiation of prescription stimulants.
For example, results of our previous study found
that initiation of prescription stimulant drugs
after elementary school is associated with
increased risk of illicit use of prescription
stimulants during college.8 However, research is
limited regarding the relationship between
initiation of prescription stimulants among
specific age groups and use and abuse of alcohol
and other drugs.
Our primary objective was to investigate illicit
use and abuse of prescription stimulants, alcohol,
and other drugs based on the age of initiation of
prescription stimulants among an undergraduate
college student sample in the United States.  This
study builds on our earlier work8 by assessing the
effect of age at initiation of prescription
stimulants on substance abuse as indicated by
brief screening instruments and coingestion of
alcohol and illicit prescription stimulants.
Methods
Design
A Web-based survey was self-administered by
full-time undergraduate students at a large
university in the United States over a 2-month
period.  At that time, the total full-time under-
graduate population of the university was 20,138
students (10,339 women, 9799 men).  A random
sample of 5389 students was drawn from the
total student population by using data obtained
from the registrar’s office.  Each student participant
was mailed a letter that described the study and
invited participation by using a provided URL
address and unique password.  The invitation
included $2.00, and those who participated
became eligible for incentives including cash
prizes, travel vouchers, field passes to athletic
events, and iPods.  To maintain an adequate
sample size for all ethnic categories, we
oversampled an additional 652 Hispanic, 634
African-American, and 244 Asian students.
Those who did not respond were reminded by e-
mail up to 3 times.  We assessed the potential
effect of nonresponse by administering a brief
telephone survey to 159 nonrespondents and
found no significant differences in alcohol and
other drug use between respondents and
nonrespondents.
Students’ responses remained confidential and
unavailable to faculty or staff members.  A hosted
secure Web site running under the secure sockets
layer protocol was used to ensure that all
responses were securely transmitted between the
respondent’s browser and the server.  A third-
party research firm, not affiliated with the
university, was involved to set up the survey and
to store and maintain data.  All participants were
informed of the precautions that were imple-
mented to maintain confidentiality.  Students
were aware of the purpose of this study and that
participation was voluntary.  The institutional
review board at the host university approved the
study’s protocol, and informed consent was
provided online by all student participants.
Additional information regarding the design and
details pertaining to the Web-based approach
used in this study are reported elsewhere.9
Measures
The survey was designed by a multidisciplinary
team of clinician-researchers with backgrounds in
pharmacy, social work, nursing, and psychology.
It was developed to examine a broad range of
alcohol and other drug use behaviors among
college students.  Some of these behaviors are
described in more detail below.
Demographic measures included sex, age, race-
ethnicity, fraternity or sorority affiliation, annual
family income, and type of high or secondary school.
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Age at initiation of prescription use of
stimulants was assessed by asking the question,
“Based on a doctor’s prescription, when did you
first start using each prescription drug?”
“Stimulants (e.g., Ritalin, Dexedrine, Adderall,
Concerta, and methylphenidate)” was specified
as one of seven prescription drug categories.  The
response scale was as follows:  grades
kindergarten (K)–4, grades 5–6, grades 7–8,
grades 9–10, grades 11–12, college, and rather
not say.  Responses were collapsed into four
categories of prescription use:  grades K–4,
grades 5–8, grades 9–12, and college.  For
purposes of analysis, these four categories were
compared with those who were never prescribed
stimulants.
Past-month illicit use of prescription stimulants
was assessed with the question, “On how many
occasions in the past 30 days have you used the
following types of drugs, not prescribed to you?”
“Stimulant medications (e.g., Ritalin, Dexedrine,
Adderall, Concerta, and methylphenidate)” was
provided as one of four categories.
Past-month use of marijuana was assessed with
the question, “On how many occasions in the
past 30 days have you used the following types of
drugs?  Do not include drugs used under a
doctor’s prescription.”  “Marijuana or hashish”
was among the eight choices provided.
Past-month use of illicit drugs other than
marijuana was assessed with the question, “On
how many occasions in the past 30 days have you
used the following types of drugs?  Do not
include drugs used under a doctor’s prescription.”
There were separate items for each of the
following seven drugs:  cocaine, lysergic acid
diethylamide (LSD), other psychedelics, crystal
methamphetamine, heroin, inhalants, and
ecstasy.  An index was created by summing use of
any of these seven drugs.
Past-month illicit use of prescription drugs
(other than prescription stimulants) was assessed
with the question, “On how many occasions in
the past 30 days have you used the following
types of drugs, not prescribed to you?”  There
were separate items for each of the following
three classes of prescription drugs:  sleeping
agent (e.g., Ambien, Halcion, Restoril, temazepam,
triazolam); sedative or anxiety drug (e.g., Ativan,
Xanax, Valium, Klonopin, diazepam, lorazepam);
pain reliever (i.e., opioids such as Vicodin,
OxyContin, Tylenol No. 3 with codeine,
Percocet, Darvocet, morphine, hydrocodone,
oxycodone).  An index was created by summing
use of any of these three classes of prescription
drugs.
The response scale used for each of the above
items was as follows:  no occasions, 1–2 occasions,
3–5 occasions, 6–9 occasions, 10–19 occasions,
20–39 occasions, 40 or more occasions.  For
purposes of analysis, responses to each item were
collapsed into two categories:  use on at least one
occasion and no use.
Past year coingestion of alcohol and illicit
prescription stimulants was assessed with the
question, “In the past 12 months, how many days
have you used prescription stimulant medication
(e.g., Ritalin, Dexedrine, Adderall, Concerta,
methylphenidate), not prescribed to you by a
doctor at the same time you were drinking
alcohol?”  Respondents were asked to enter the
number of days in a text box.  For purposes of
analysis, responses were collapsed into two
categories:  use on at least one occasion and no
use.
Alcohol abuse was assessed by including a
modified version of the Cut Down, Annoyance,
Guilt, Eye-opener (CAGE) instrument, a
standard, four-item, brief alcoholism screening
instrument.10 Respondents were asked how
many times in the past year they had experienced
each of the four CAGE criteria:  C, “Felt that you
should cut down on your drinking”; A, “Been
annoyed by people criticizing your drinking”; G,
“Felt guilt or remorse after drinking”; and E,
“Had a drink first thing in the morning as an eye-
opener or to get rid of a hangover.”  If a student
indicated that they had experienced two or more
of these criteria in the past year, this was consid-
ered a positive screening test result, denoting
suspected alcohol abuse.11, 12 If a student had
experienced none or only one of the four criteria,
they were assigned a negative test result.
Drug use–related problems were assessed with
a slightly modified version of the Drug Abuse
Screening Test, short form (DAST-10), which is a
self-report instrument that can be used in both
clinical and nonclinical settings to screen for
abuse of and dependence on a wide variety of
substances other than alcohol.13 The DAST was
originally adapted from the Michigan Alcoholism
Screening Test, or MAST, which focuses primarily
on alcohol, and the two scales are very similar.
Furthermore, the original 28-item version, the
more recent 20-item version, and the 10-item
version of the DAST are highly correlated, with a
correlation coefficient of r=0.99 for the 28-item
version and the 20-item version, and r=0.97 for
the 20-item version and the 10-item version.13, 14
We used a cutoff point score of 3 to identify
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students with potential drug abuse problems.  A
cutoff point of 2 has been shown to achieve an
appropriate balance between sensitivity and
specificity14, 15; therefore, a cutoff point of 3 is a
more conservative approach that should help
avoid false-positive findings.
Data Analysis
Prevalence rates were derived by dividing the
number of students reporting an outcome
behavior by the total number of responses to that
question.  Bivariate associations between student
characteristics and outcome prevalence rates
were tested by using x2 analyses.  Multiple
logistic regression analyses were conducted to
examine the associations between student
characteristics and the dichotomous drug use
outcomes after statistically controlling for other
background characteristics (e.g., sex, affiliation
with fraternity or sorority, race-ethnicity, family
income, and type of secondary or high school).
Adjusted odds ratios (ORs) and 95% confidence
intervals (CIs) are provided.  All statistical
analyses were performed with use of SPSS 13.0
statistical software (SPSS Inc., Chicago, IL).
Results
Sample
The overall response rate for this study was
66%, and the final sample included 4580
undergraduate students (3639 from the random
sample and 941 from the oversample).  Unweighted
sex and racial distribution of the random sample
was 54% women and 46% men; and 67%
Caucasian, 12% Asian, 6% African-American, 4%
Hispanic, and 10% from other ethnic categories.
The total university population consisted of 51%
women, 49% men, 65% Caucasian, 14% Asian,
6% African-American, 4% Hispanic, and 11%
from other ethnic categories.  The mean ± SD age
of students in the sample was 20 ± 2.0 years.  A
sample weight variable was created to account for
oversampling of racial minorities, and data were
weighted for analyses of the overall sample to
increase the representativeness of our results.
The weight variable was centered (normalized) to
ensure that sample size remained the same after
weighting.  As a result, our sample closely
resembled the overall student population with
regard to demographic characteristics.
We created five subgroups of users based on
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Table 1.  Selected Demographics Across Different Subgroups of Respondents
Total Student No Prescription Age at Initiation of Prescription Stimulants
Sample Stimulant Use Grades K–4 Grades 5–8 Grades 9–12 College
Characteristic (n=4580) (n=4266) (n=36) (n=26) (n=62) (n=73)
Sex
Male 49.7 49.0 85.0 84.6 58.8 48.9
Female 50.3 51.0 15.0 15.4 41.2 51.1
Race-ethnicity
Caucasian 65.1 65.2 73.8 68.6 65.2 71.5
African-American 6.9 7.1 1.3 0.0 5.8 5.6
Asian 13.1 13.3 8.7 11.6 4.9 8.3
Hispanic 4.5 4.4 2.0 5.9 8.3 7.6
Other 10.3 10.0 14.2 13.9 15.8 7.0
Fraternity-sorority status
Nonmember 86.7 87.4 96.4 90.2 71.2 62.3
Member 13.3 12.6 3.6 9.8 28.8 37.7
Annual family income ($)
< 50,000 12.4 12.8 15.3 22.0 4.7 10.3
50,000–99,000 22.9 23.3 10.3 16.4 14.8 21.3
100,000–149,000 17.9 18.2 17.2 20.0 18.7 11.1
150,000–250,000 11.7 11.8 7.2 10.0 9.3 14.2
> 250,000 9.1 8.4 19.0 8.0 30.3 21.3
Don’t know or refused 25.8 25.8 31.1 23.2 22.1 21.8
Type of high or secondary
school
Public 81.4 81.6 84.6 69.2 71.9 84.4
Private religious 11.1 11.1 15.4 16.4 11.5 7.5
Other private 6.4 6.2 0.0 9.3 16.6 8.0
Home school 1.1 1.1 0.0 5.0 0.0 0.0
Data are percentages.  Sample sizes and percentages are based on weighted data.
K = kindergarten.
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age at initiation of prescription stimulant use:  no
prescription stimulant use (4266 students),
grades K–4 (36), grades 5–8 (26), grades 9–12
(62), and college (73); some students preferred
not to answer this particular question.  Demographic
characteristics differed across the five subgroups
of prescription stimulant use (Table 1).
Past-Month Illicit Use of Prescription Stimulants
Bivariate analyses (Table 2) showed that
approximately 2% of students who reported no
previous use of prescription stimulants
responded that they had illicitly used a stimulant
in the past month, as opposed to students who
began prescription stimulant use in grades 9–12
(8.2%) and college (22.7%).  Results from
multiple logistic regression analyses (Table 3)
indicated that the odds of illicit use of prescrip-
tion stimulants (use vs no use) was 13 times
higher among those who started use of prescrip-
tion stimulants in college compared with
students who were never prescribed a stimulant.
No statistically significant differences were noted
between the group that had no prescription
stimulant use and the grades 9–12, grades 5–8,
and grades K–4 groups in the odds of illicit use of
prescription stimulants.
Past-Month Use of Marijuana
Bivariate analyses (Table 2) showed that a
greater percentage of students who started
prescription stimulant use in high school
(45.8%) and college (50.5%) used marijuana
within the past month than did students who
started prescription stimulant use in grades K–4
(10.9%), grades 5–8 (21.4%), and those who had
never been prescribed stimulants (19.1%).
Results from multiple logistic regression analysis
(Table 3) indicate that the odds of past-month
marijuana use was almost 3 times higher among
the grades 9–12 initiators and were more than 3
times higher in college initiators when compared
with the group that had no prescription stimu-
lant use.  No statistically significant differences
were noted between the group that had no
prescription stimulant use and the grades K–4
and grades 5–8 groups in the odds of past-month
marijuana use.
Past-Month Use of Illicit Drugs Other Than
Marijuana
The bivariate analyses (Table 2) demonstrated
that approximately 12.1% of students who started
a prescription stimulant in college reported use
of other illicit drugs including cocaine, crystal
methamphetamine, heroin, inhalants, ecstasy,
LSD, and other psychedelics in the past month.
This percentage was higher than those of the
other groups.  Multiple logistic regression
analyses (Table 3) indicated that the odds of
using an illicit drug other than marijuana within
the past month were almost 5 times higher
among college prescription stimulant initiators
and more than 3 times higher among grades 9–12
initiators when compared with the group that
had no prescription stimulant use.  No statistically
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Table 2.  Bivariate Results for Prevalence of Illicit Use and Abuse of Prescription Stimulants, Alcohol, and Other Drugs as a
Function of Age at Initiation of Prescription Stimulants
No Prescription Age at Initiation of Prescription Stimulants
Stimulant Use Grades K–4 Grades 5–8 Grades 9–12 College
Variable (n=4266) (n=36) (n=26) (n=62) (n=73)
Past-month illicit use of
prescription stimulants 1.8 3.6 5.6 8.2 22.7
Past-month marijuana use 19.1 10.9 21.4 45.8 50.5
Past-month use of illicit
drugs other than marijuanaa 2.2 3.6 5.0 7.2 12.1
Past-month illicit use of
prescription drugsb 3.0 3.1 10.0 14.3 19.9
Past-year coingestion of
alcohol and illicit
prescription stimulants 2.6 3.6 5.0 12.6 23.3
Past-year CAGE (score ≥ 2) 19.3 24.1 38.5 36.0 37.6
Past-year DAST-10 (score ≥ 3) 8.7 21.0 20.0 30.3 31.0
Data are percentages.  Sample sizes and percentages are based on weighted data.
K = kindergarten; CAGE = Cut Down, Annoyance, Guilt, Eye-opener; DAST-10 = Drug Abuse Screening Test, short form.
aRefers to use of any of the following illicit drugs:  cocaine, LSD, other psychedelics, crystal methamphetamine, heroin, inhalants, and ecstasy.
bRefers to illicit use of opioid analgesics, sedatives or anxiolytics, or sleeping agents.
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significant differences were noted between the
group that had no prescription stimulant use and
the grades K–4 and grades 5–8 groups in the
odds of past month use of illicit drugs (other
than marijuana).
Past-Month Illicit Use of Prescription Drugs
Other Than Prescription Stimulants
Results from bivariate analyses (Table 2)
indicated that approximately 20% of students
who started a prescription stimulant in college
also illicitly used a prescription drug such as an
opioid analgesic, a sedative or tranquilizer, or a
sleeping agent.  Also, about 14% of high school
initiators reported past-month illicit use of other
prescription drugs.  Both high school and college
initiators had higher rates of illicit use of other
prescription drugs compared with the other
groups.  Multiple logistic regression analyses
(Table 3) showed that the odds of past-month
illicit use of prescription drugs was more than 6
times higher in the college initiation of
prescription stimulant group compared with the
group that had no prescription stimulant use.
Further, the odds of illicit prescription drug use
were almost 7 times higher for the grades 9–12
initiation group compared with the group that
had no prescription stimulant use.  No statis-
tically significant differences were noted between
the group that had no prescription stimulant use
and the grades K–4 and grades 5–8 groups in the
odds of past-month illicit use of prescription
drugs other than stimulants.
Past-Year Coingestion of Alcohol and Illicit
Prescription Stimulants
Bivariate results (Table 2) indicated that 2.6%
of the college students who had no previous use
of a prescription stimulant reported past-year
coingestion of alcohol with an illicit prescription
stimulant.  The prevalence rates of students
reporting coingestion of alcohol with a stimulant
who started a prescription stimulant in either
grades K–4 or grades 5–8 were similar to that of
the group that had no prescription stimulant use.
Higher prevalence rates were found among the
grades 9–12 and college initiation groups.
Results from multiple logistic regression analyses
(Table 3) showed that initiation in grades 9–12
increased the odds of coingestion of alcohol with
a stimulant by a factor of 3.7.  Further, those who
reported initiation of prescription stimulant use
in college were almost 10 times more likely to
report coingestion of alcohol and illicit
prescription stimulants.  Once again, no
statistically significant differences were noted
between the group that had no prescription
stimulant use and the grades K–4 and grades 5–8
groups in the odds of past-month coingestion of
alcohol and illicit prescription stimulants.
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Table 3.  Multivariate Results for Relationships Between Age at Initiation of Prescription Stimulants and Illicit Use and
Abuse of Prescription Stimulants, Alcohol, and Other Drugs
Age at Initiation of Prescription Stimulants
Variable Grades K–4 Grades 5–8 Grades 9–12 College
Past-month illicit use of 2.9 (0.4–24.0) 3.8 (0.6–23.9) 3.7 (0.9–14.2) 13.0 (5.3–32.2)a
prescription stimulants
Past-month marijuana use 0.4 (0.1–1.9) 1.6 (0.5–5.1) 2.8 (1.6–4.7)b 3.2 (1.7–6.1)a
Past-month use of illicit 1.4 (0.2–11.4) 2.1 (0.3–16.6) 3.2 (1.0–9.6)b 4.8 (1.9–12.3)a
drugs other than marijuanac
Past-month illicit use of 1.0 (0.1–8.0) 4.6 (0.9–22.2) 6.9 (2.6–13.9)a 6.4 (2.9–14.1)a
prescription drugsd
Past-year coingestion of 1.4 (0.2–11.5) 2.1 (0.2–18.5) 3.7 (1.5–9.3)e 9.7 (4.7–19.5)a
alcohol and illicit
prescription stimulants
Past-year CAGE (score ≥ 2) 1.5 (0.6–3.5) 2.8 (1.1–6.9)b 1.9 (1.1–3.5)b 2.0 (1.2–3.5)e
Past-year DAST–10 (score ≥ 3) 2.8 (0.9–8.0) 3.1 (0.9–10.3) 3.6 (1.8–7.3)a 3.7 (1.9–7.1)a
Data are odds ratios (95% confidence intervals).
K = kindergarten; CAGE = Cut Down, Annoyance, Guilt, Eye-opener; DAST-10 = Drug Abuse Screening Test, short form.
The group that had no prescription stimulant use was used as the reference group; results were adjusted by controlling for demographics (sex,
fraternity or sorority affiliation, race-ethnicity, family income, and type of secondary or high school).
ap<0.001.
bp<0.05.
cRefers to use of any of the following illicit drugs: cocaine, LSD, other psychedelics, crystal methamphetamine, heroin, inhalants, and ecstasy.
dRefers to illicit use of opioid analgesics, sedatives or anxiolytics, or sleeping agents.
ep<0.01.
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Alcohol Abuse
Students who started a prescription stimulant
in grades 5–8, grades 9–12, and college had
higher rates of alcohol abuse indicators compared
with those rates for students who started
prescription stimulant use in grades K–4 and
those who reported no prescription stimulant use
(Table 2).  Consistent with these bivariate
findings, the results from multiple logistic
regression analyses (Table 3) indicated that the
odds of screening positive for possible alcohol
abuse in college were higher among students
who started prescription stimulant use in grades
5–8, grades 9–12, and college compared with the
group that had no prescription stimulant use.  No
statistically significant difference was noted
between the grades K–4 group and the group that
had no prescription stimulant use in the odds of
alcohol abuse indicators.
Drug Use–Related Problems
Bivariate results (Table 2) showed that the age
of initiation of prescription stimulants was
associated with reporting three or more drug
use–related problems based on the DAST-10
questionnaire.  After controlling for student
demographics, multiple logistic regression
analyses (Table 3) revealed a significant increase
in the odds of drug abuse in college (OR 3.7) and
grades 9–12 (OR 3.6) initiators as compared with
students who were never prescribed a stimulant.
In contrast, those students who started
prescription stimulants in grades K–4 or grades
5–8 did not differ significantly from the group
that had no prescription stimulant use in the
odds of drug use–related problems.
Discussion
Our main objective while conducting this
research was to assess the associations between
age at initiation of prescription stimulant drugs
and illicit use and abuse of prescription
stimulants, alcohol, and other drugs.  Results
showed that the age at which a person reports
being prescribed a stimulant drug was
significantly associated with use and abuse of
other substances during college.  In particular,
one of the most important findings of this study
was that students who had been prescribed a
stimulant in elementary school (grades K–4)
reported similar rates of substance use as those
who were never prescribed a stimulant drug.
These results are in concordance with those of
previous research, which showed that starting a
prescription stimulant drug during childhood
does not appear to increase the risk of future
substance use disorders.8, 16–18 Conversely,
students who started prescription use of a
stimulant drug in college were significantly more
likely than students who were never prescribed a
stimulant to report alcohol and other drug use.
These results are similar to those of our earlier
work, which found that college students who
started prescription stimulants after elementary
school were 2–7 times more likely than nonusers
to report past-year illicit use of prescription
stimulants, marijuana, cocaine, and other illicit
drugs.8
When we examined the coingestion of alcohol
and illicit prescription stimulants as a function of
initiation of prescribed use of stimulants and
screened for alcohol- and drug-related problems,
we found similar results.  Students who started
use of prescription stimulants in either high
school or college were found to have significantly
higher prevalence rates of past-year coingestion
of alcohol and prescription stimulants and to
meet two or more past-year CAGE criteria, as
well as three or more DAST-10 criteria.
Reasons for the increased illicit use of
prescription stimulants, alcohol, and other drugs
among those prescribed a stimulant drug in
college are unclear.  Perhaps the students who
started prescription stimulants in college were
previously untreated and were therefore at
greater risk for developing drug use problems.
Alternatively, the motives for students who
misuse prescription stimulants may provide some
insight into this phenomenon.  For example,
results from one study showed that most
students who used prescription stimulants
illicitly did so in order to improve concentration,
help study, and increase alertness.19 It may be
that students are obtaining prescription
stimulants for reasons other than treatment.
Clearly, more research is needed to answer this
important question.
Limitations
Several limitations should be noted while
reviewing the results of this study.  Nonresponse
may have introduced some bias in this study.  To
examine the possibility of nonresponse bias, we
conducted a telephone follow-up survey of 159
randomly selected nonrespondents.  Most
notably, no differences occurred in prevalence
rates of alcohol use, cigarette smoking, and other
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problem health behaviors between respondents
and nonrespondents.  Also, the manner of data
collection was a self-administered Web-based
survey at a single public university.  Although it
was a large university, the results may not
generalize to other populations.  The extent to
which these findings characterize other colleges
and universities is an important question for
future research.
This survey asked participants to remember
when they were first prescribed a stimulant.
Some students may not be able to recall exactly
when they began taking a drug, especially if it
was at a young age.  However, if a child receives a
diagnosis of attention-deficit–hyperactivity
disorder (ADHD), this behavioral problem could
have a strong impact on the child’s personal and
social relationships.20 Stimulant drugs have a
positive response rate of 70–90% for reducing
symptoms such as hyperactivity, impulsivity, and
inattentiveness20; therefore, it is likely that a child
would remember changes that had a strong
influence on his or her life.  It should be noted
that we do not have information regarding
duration of stimulant treatment or drug
adherence and are therefore unable to comment
on how these variables may affect our outcomes.
Another limitation to this study is our lack of
information regarding a diagnosis of ADHD.
Although we cannot make any assertions
regarding individuals who may have experienced
poor outcomes due to untreated ADHD,
questions that address initiation of prescription
stimulants, as described in our methods, give
examples only of stimulant drugs used to treat
ADHD.  Furthermore, our current results are
comparable to those of our previous study that
used a similar survey methodology, but specified
stimulant drugs for ADHD in questions regarding
medical and illicit use.8 Finally, previous
research has shown that most stimulants are
prescribed to treat ADHD as compared to any
other indication.20
This study included participants who started
prescription stimulants at several ages (e.g.,
grades K–4, grades 5–8, grades 9–12, and
college).  However, our sample consisted of
college students, and we do not have data on
students who began a stimulant drug before
college age, but did not attend college.  It would
be beneficial if a prospective trial was conducted
to follow all children given a stimulant drug at
different ages of initiation in order to examine
subsequent alcohol and other drug use behaviors,
regardless of whether or not they attended
college.
Furthermore, although the sample size was
sufficient to examine differences between
nonusers and several groups based on age at
initiation, we were unable to examine differences
between early versus late initiators with use of
multivariate analysis because of the small
numbers of respondents within each stratified
group.  Future research should consider
recruiting adequate numbers to allow for
comparisons of substance abuse outcomes
between early versus late initiators.
Finally, embedding the CAGE and DAST-10
into our survey is another aspect that should be
considered while evaluating our results.  Previous
research has shown that use of the CAGE in
adolescent populations is not recommended due
to insufficient sensitivity in young patients.12
The adolescent population in that study was aged
14–18 years; therefore, this may not pertain to
our results as our population included mainly
those aged 18–24 years.  In addition, sensitivity
is lower for the CAGE than for other alcohol
screening options, but it does have higher
specificity.11, 12 Regarding the DAST-10, we used
a cutoff score of 3 or greater to determine
significant differences in terms of drug abuse
indicators, which is a more conservative measure
than has been used previously.  Different studies
have shown a cutoff point of 2 to be appropriate
for both sensitivity and specificity; however,
these studies were conducted in psychiatric
populations.14, 15 Our results for the CAGE and
DAST-10 should be interpreted with caution, but
it is important to note that the results of the
CAGE and DAST-10 are complementary to the
other alcohol and drug use outcomes that were
included in the study, including measures of
prescription drug abuse.
Conclusion
Despite the above limitations, this study builds
on previous work by examining the association
between age at initiation of prescription
stimulants and several measures of substance use.
By including screening measures for alcohol
abuse (CAGE) and drug abuse (DAST-10), we
were able to move beyond assessing whether or
not students had ever engaged in various
substance use behaviors (which could range from
experimental use to dependence) to indicators of
potential abuse.  Screening for substance abuse
among these students may be more informative
in terms of assessing adverse consequences of
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drug use.
Students whose use of prescription stimulants
started in college were at a significantly increased
risk for alcohol and other drug use as compared
with students with no previous use of a
prescription stimulant.  Conversely, students
whose use of a prescription stimulant started in
grades K–4 did not show any differences in
alcohol or other drug use as compared with
students with no previous prescription stimulant
use.  Longitudinal research on the characteristics
and trajectories of prescription stimulant use will
enhance our understanding of the implications of
these drugs for subsequent substance use.
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